Yellowstone Advisory

Yellowstone Advisory is an active private limited company incorporated in the United Kingdom in December 2016. It provides management consultancy services focused on investor relations, financial communications, and strategic advice primarily to public companies and those preparing for IPOs. The firm does not operate within the life sciences, biotech, pharma, or healthcare sectors as a core business; its expertise lies instead in capital markets communication and strategy for corporate clients—especially those involved with UK small/mid-cap equities. The founder and managing director is Alex Schlich, who has extensive experience in fund management and investment banking. Other key team members include consultants with backgrounds in financial PR and investor relations. There are no indications of drug development programs, therapeutic modalities, clinical pipeline activity, or manufacturing capabilities related to pharmaceuticals or biotechnology.